Literature DB >> 23185961

Spontaneous regression of chronic lymphocytic leukemia to a monoclonal B-lymphocytosis or to a normal phenotype.

Peter S Nakhla1, James N Butera, Diana O Treaba, Jorge J Castillo, Peter J Quesenberry.   

Abstract

Spontaneous remission of chronic lymphocytic leukemia (CLL) is an unusual and poorly characterized event. We performed a search for spontaneous remission in patients with CLL. Cases must have had a pathological diagnosis of CLL with disease duration > 6 months. Spontaneous remission was defined as absence of lymphadenopathy or splenomegaly with lymphocyte counts < 5 × 10(9)/L for > 9 months without therapy. We identified 20 cases and included one additional case from our institution. Fourteen cases (67%) showed remission into monoclonal B lymphocytosis (MBL) and seven (33%) into a normal phenotype. There was no difference in age distribution, lymphocyte count or stage between groups. There was a significant difference in the median duration of CLL prior to remission, 13 years in the MBL versus 3 years in the normal phenotype group (p = 0.03). This difference in the duration of CLL prior to remission could be due to a possible distinct pathophysiology for these events.

Entities:  

Mesh:

Year:  2013        PMID: 23185961     DOI: 10.3109/10428194.2012.753449

Source DB:  PubMed          Journal:  Leuk Lymphoma        ISSN: 1026-8022


  3 in total

1.  CLL: Common Leukemia; Uncommon Presentations.

Authors:  Deepesh Lad; Pankaj Malhotra; Neelam Varma; Manupdesh Singh Sachdeva; Ashim Das; Radhika Srinivasan; Amanjit Bal; Alka Khadwal; Gaurav Prakash; Vikas Suri; Savita Kumari; Sanjay Jain; Subhash Varma
Journal:  Indian J Hematol Blood Transfus       Date:  2014-12-24       Impact factor: 0.900

2.  High Viral Loads of Epstein-Barr Virus DNA in Peripheral Blood of Patients with Chronic Lymphocytic Leukemia Associated with Unfavorable Prognosis.

Authors:  Ewelina Grywalska; Jacek Roliński; Marcin Pasiarski; Izabela Korona-Glowniak; Maciej Maj; Agata Surdacka; Agnieszka Grafka; Agnieszka Stelmach-Gołdyś; Michał Zgurski; Stanisław Góźdź; Anna Malm; Piotr Grabarczyk; Elżbieta Starosławska
Journal:  PLoS One       Date:  2015-10-13       Impact factor: 3.240

3.  A Case of Complete and Durable Molecular Remission of Chronic Lymphocytic Leukemia Following Treatment with Epigallocatechin-3-gallate, an Extract of Green Tea.

Authors:  Dawn Lemanne; Keith I Block; Bruce R Kressel; Vikas P Sukhatme; Jeffrey D White
Journal:  Cureus       Date:  2015-12-29
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.